COZAAR Label update October 2022

COZAAR Label update October 2022

3rd Grade

8 Qs

quiz-placeholder

Similar activities

QBOW Staff Retreat

QBOW Staff Retreat

1st - 5th Grade

8 Qs

BCU July 2024

BCU July 2024

1st - 5th Grade

10 Qs

TBL_iRAT_Plasma Cell Neoplasm

TBL_iRAT_Plasma Cell Neoplasm

1st - 9th Grade

5 Qs

Banca seguros

Banca seguros

3rd Grade

10 Qs

ADHD  and 504

ADHD and 504

KG - Professional Development

10 Qs

Luscii turns One

Luscii turns One

1st - 6th Grade

11 Qs

pre test dan post test

pre test dan post test

1st - 12th Grade

10 Qs

Pleural, Emboli, Edema, Terapi Oksigen

Pleural, Emboli, Edema, Terapi Oksigen

KG - Professional Development

10 Qs

COZAAR Label update October 2022

COZAAR Label update October 2022

Assessment

Quiz

Professional Development

3rd Grade

Medium

Created by

Nthabiseng Mashaphu

Used 2+ times

FREE Resource

8 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

COZAAR is now packed in a pack of 25s, 50s and 100

TRUE

FALSE

2.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

What is the recommended dose in patients 6-16 years of age, weighing 20 or less than 50 kg

50 mg once daily

100 mg once daily

25 mg once daily

3.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

What is the recommended dose in patients 6-16 years of age, weighing more than or equals to 50 kg

50 mg once a day

25 mg once a day

100 mg once a day

4.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

The safety and efficacy use in of children has not been established from what age in paediatric population?

6 months-2 years

2-6 years

6 months-less than 6 years

6 years and younger

5.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

Concomitant use of fluoroquinolones with ACE inhibitors/Renin-Angiotensin is contraindicated in which patients?

Only moderate renal impairment

Only severe renal impairment

Mild to noderate renal impairment

Moderate to severe renal impairment

6.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

COZAAR is safe for administration with aliskerin in patients with diabetes?

FALSE

TRUE

7.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

Administration of aliskerin with COZAAR in patients with diabetes should be given with caution?

TRUE

FALSE

8.

FILL IN THE BLANK QUESTION

1 min • 5 pts

What should be assessed before initiating treatment with fluoroquinolones or ACE inhibitors/Renin Angiotensin receptor blockers?